Related Experiment Video
Updated: May 4, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Development of phosphocellulose paper-based screening of inhibitors of lipid kinases: case study with PI3Kβ
Mahesh Yanamandra1, Labanyamoy Kole2, Archana Giri3
1Biology Division, GVK Biosciences Pvt. Ltd., Hyderabad 500076, Andhra Pradesh, India; Centre for Biotechnology, Institute of Science and Technology, Jawaharlal Nehru Technological University Hyderabad, 500085 Hyderabad, Andhra Pradesh, India.
Abstract:
The phosphatidylinositol 3-kinases (PI3Ks) are lipid kinases that regulate the cellular signal transduction pathways involved in cell growth, proliferation, survival, apoptosis, and adhesion. Deregulation of these pathways are common in oncogenesis, and they are known to be altered in other metabolic disorders as well. Despite its huge potential as an attractive target in these diseases, there is an unmet need for the development of a successful inhibitor. Unlike protein kinase inhibitors, screening for lipid kinase inhibitors has been challenging. Here we report, for the first time, the development of a radioactive lipid kinase screening platform using a phosphocellulose plate that involves transfer of radiolabeled [γ-(32)P]ATP to phosphatidylinositol 4,5-phosphate forming phosphatidylinositol 3,4,5-phosphate, captured on the phosphocellulose plate. Enzyme kinetics and inhibitory properties were established in the plate format using standard inhibitors, such as LY294002, TGX-221, and wortmannin, having different potencies toward PI3K isoforms. ATP and lipid apparent Km for both were determined and IC50 values generated that matched the historical data. Here we report the use of a phosphocellulose plate for a lipid kinase assay (PI3Kβ as the target) as an excellent platform for the identification of novel chemical entities in PI3K drug discovery.
Insights
Researchers developed a novel radioactive assay for screening phosphatidylinositol 3-kinases (PI3K) inhibitors. This phosphocellulose plate assay enables efficient identification of new drug candidates for cancer and metabolic disorders.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Phosphatidylinositol 3-kinases (PI3Ks) are crucial lipid kinases regulating vital cellular processes.
- Dysregulation of PI3K pathways is implicated in oncogenesis and metabolic disorders.
- Developing effective PI3K inhibitors is challenging due to difficulties in lipid kinase screening.
Purpose of the Study:
- To establish a novel radioactive screening platform for lipid kinases.
- To validate the platform's utility for identifying PI3K inhibitors.
Main Methods:
- Development of a phosphocellulose plate-based assay using radiolabeled [γ-(32)P]ATP.
- Quantification of phosphatidylinositol 3,4,5-phosphate formation.
- Enzyme kinetics and inhibitor profiling using known PI3K inhibitors (LY294002, TGX-221, wortmannin).
Main Results:
- The assay successfully measures PI3K activity and inhibitor potency.
- Kinetic parameters (Km) and IC50 values were accurately determined.
- The platform demonstrated reliability by matching historical data for standard inhibitors.
Conclusions:
- A novel, efficient radioactive phosphocellulose plate assay for PI3K was developed.
- This platform is suitable for identifying novel chemical entities for PI3K-targeted drug discovery.
- The assay provides a valuable tool for advancing PI3K inhibitor development.
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...

